WA

Waystar Holding Corp.

WAYHealthcareNASDAQ

Health Information Services

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.10B
+16.5% YoY
Net Income
$112.1M
+686.1% YoY
EBITDA
$389.9M
+25.6% YoY
Free Cash Flow
$313.7M

Scan Results

Daily timeframe
3 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 16CONFIRMED▼ RSI OverboughtRSI 71.7, above 70, stock may be overbought
Oct 9▲ MACD Positive CrossoverHistogram +0.0665, positive momentum
About Waystar Holding Corp.

Part of the healthcare sector, Waystar Holding Corp. (WAY) is listed under Health Information Services. The $5.53B market capitalization puts WAY squarely in mid-cap range for its industry. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and revenue capture, and analytics and reporting solutions.

Where WAY stands vs its 150-day and 200-day moving averages

As of the October 16, 2026 close, WAY finished 22.73% above its 150-day moving average ($23.01) and 17.18% above its 200-day moving average ($24.10). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is WAY overbought or oversold?

At the October 16, 2026 close, WAY's RSI(14) was 71.7, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$5.53B
P/E (TTM)41.21
Fwd P/E15.35
EPS$0.70
Beta0.18
52W Change-26.7%
Dividend Yield0.00%
ROE3.8%
Analysis

The company holds $193.5M in cash, though total debt stands at $1.48B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $313.7M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 3.8%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.4% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $704.9M (2022) to $1.10B (2025), reflecting a 56% increase over the period.

With a beta below 0.7, Waystar Holding Corp. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Waystar Holding Corp. and its sector.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms